Jenny Leeds is an investor for Counterpoint Global. She joined Morgan Stanley in 2019 and has five years of investment experience. Prior to joining the firm, she was an associate and Equity Research Analyst at Bank of America Merrill Lynch (BAML) focused on biotechnology. Jenny received a Ph.D. in cancer biology and immunology from Memorial Sloan Kettering Cancer Center and a B.S. in biochemistry from Tufts University.
Jenny is a member of Counterpoint Global


This is a Marketing Communication.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.